Mark A. Kay

Mark A. Kay

Direttore/Membro del Consiglio presso
Genevant Sciences Corp.
68 anni
Consumer Services
Health Technology
Commercial Services

Profilo

Mark A. Kay is the founder of Voyager Therapeutics, Inc. (2013), American Society of Gene & Cell Therapy (2005), and LogicBio Therapeutics, Inc. (2014).
He held the title of President at American Society of Gene & Cell Therapy from 2005 to 2006 and the title of Independent Director at LogicBio Therapeutics, Inc. from 2016 to 2022.
Currently, he is an Independent Director at Genevant Sciences Corp.
since 2018 and a Professor & Head-Human Gene Therapy Division at Stanford University School of Medicine since 1998.
Dr. Kay received his undergraduate degree from Michigan State University and his doctorate from Case Western Reserve University.

Posizioni attive di Mark A. Kay

SocietàPosizioneInizio
Corporate Officer/Principal 01/01/1998
Direttore/Membro del Consiglio 19/11/2018

Precedenti posizioni note di Mark A. Kay

SocietàPosizioneFine
LOGICBIO THERAPEUTICS, INC. Fondatore 16/11/2022
Fondatore 01/01/2006
VOYAGER THERAPEUTICS, INC. Fondatore -
Vedi nel dettaglio l'esperienza di Mark A. Kay

Formazione di Mark A. Kay

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

73

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Mark A. Kay